Diana Lee Farmer赞助的临床试验
总计1211个结果
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)完全的淋巴瘤 | 骨髓增生异常综合征 | 白血病 | 骨髓瘤 | 移植物抗宿主病美国
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)完全的
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)完全的肉瘤 | 肾癌 | 睾丸生殖细胞肿瘤 | 头颈癌 | 卵巢癌 | 肺癌 | 脑和中枢神经系统肿瘤 | 未明确的成人实体瘤,特定方案 | 膀胱癌 | 性腺外生殖细胞瘤 | 不明原发癌美国
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)完全的
-
Massachusetts General HospitalNovartis; Dana-Farber Cancer Institute完全的
-
Dana-Farber Cancer InstituteBrigham and Women's Hospital完全的
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)完全的
-
Dana-Farber Cancer InstituteBrigham and Women's Hospital终止
-
Dana-Farber Cancer InstituteBrigham and Women's Hospital完全的
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)完全的
-
Dana-Farber Cancer InstituteBrigham and Women's Hospital完全的
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)未知
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's Hospital; Amgen; H. Lee Moffitt Cancer Center...完全的
-
Dana-Farber Cancer InstituteBreast Cancer Research Foundation招聘中
-
Dana-Farber Cancer InstituteBlue Earth Diagnostics, Inc尚未招聘
-
Christine RyanGenentech, Inc.招聘中
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)招聘中
-
Dana-Farber Cancer InstituteEli Lilly and Company招聘中
-
Dana-Farber Cancer InstituteCharles H. Hood Foundation招聘中
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)招聘中
-
Dana-Farber Cancer InstituteGateway for Cancer Research招聘中上皮样肉瘤 | 非典型畸胎瘤样/横纹肌样瘤 | 恶性横纹肌瘤 | 肾脏横纹肌样瘤 | 脊索瘤(低分化或去分化) | 其他 INI1 阴性肿瘤(经 PI 批准) | 其他 SMARCA4 缺陷型恶性肿瘤(经 PI 批准)美国
-
Dana-Farber Cancer InstituteBreast Cancer Research Foundation招聘中
-
Dana-Farber Cancer InstituteEli Lilly and Company招聘中
-
Dana-Farber Cancer InstituteBrigham and Women's Hospital招聘中
-
M.D. Anderson Cancer CenterDana-Farber Cancer Institute主动,不招人
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)主动,不招人
-
Dana-Farber Cancer InstituteMerck Sharp & Dohme LLC主动,不招人
-
Dana-Farber Cancer InstituteAstraZeneca; Cyclacel Pharmaceuticals, Inc.主动,不招人
-
Dana-Farber Cancer InstituteMerck Sharp & Dohme LLC完全的
-
Dana-Farber Cancer InstituteEli Lilly and Company主动,不招人
-
Dana-Farber Cancer InstituteJanssen Research & Development, LLC主动,不招人
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)主动,不招人
-
Dana-Farber Cancer InstituteNational Comprehensive Cancer Network主动,不招人
-
Dana-Farber Cancer InstituteJanssen Scientific Affairs, LLC主动,不招人
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)完全的